Steve Herne, CEO at Unlearn – Interview Series

Steve Herne is a distinguished professional with over 25 years of experience in the pharmaceutical research and development industry. Throughout his career, he has held leadership roles at notable companies such as WCG, Bioclinica, ERT, Icon Development Solutions, Covance, MDS Pharma Services, and Inveresk Research. In these positions, Herne excelled in driving long-term growth, providing…

Read More

How AI Will Keep People Fed Amid Agriculture’s Turmoil

Before the tractor was invented, farmers worked their land tirelessly alongside beasts of burden such as horses and mules that required six acres of land for feed, per animal, each year. Fearing change, job replacement, or cost, farm owners didn’t exactly rejoice and were generally skeptical of the tractor. Still, its use eventually became standard…

Read More

When MIT’s interdisciplinary NEET program is a perfect fit

At an early age, Katie Spivakovsky learned to study the world from different angles. Dinner-table conversations at her family’s home in Menlo Park, California, often leaned toward topics like the Maillard reaction — the chemistry behind food browning — or the fascinating mysteries of prime numbers. Spivakovsky’s parents, one of whom studied physical chemistry and…

Read More

MIT researchers introduce Boltz-1, a fully open-source model for predicting biomolecular structures

MIT scientists have released a powerful, open-source AI model, called Boltz-1, that could significantly accelerate biomedical research and drug development. Developed by a team of researchers in the MIT Jameel Clinic for Machine Learning in Health, Boltz-1 is the first fully open-source model that achieves state-of-the-art performance at the level of AlphaFold3, the model from Google…

Read More

The Elusive Definition of ‘Deepfake’

A compelling new study from Germany critiques the EU AI Act’s definition of the term ‘deepfake’ as overly vague, particularly in the context of digital image manipulation. The authors argue that the Act’s emphasis on content resembling real people or events – yet potentially appearing fake – lacks clarity. They also highlight that the Act’s…

Read More
Back To Top